ARRY-797 (ARRY-371797)
Catalog No: 191112
CAS Number: 1036404-17-7
Purity: 99% Min.
ARRY-797 is an oral, selective p38 mitogen-activated protein kinase inhibitor. ARRY-797 is being studied in a Phase 3 trial in patients with lamin A/C-related dilated cardiomyopathy (LMNA-related DCM), a rare, degenerative cardiovascular disease caused by mutations in the LMNA gene and characterized by poor prognosis.
According to reaxys, the correct CAS should be “1034189-82-6", please check the correct link.
For research use only. We do not sell to patients.
Chemical Information
| Name | ARRY-797 (ARRY-371797) |
|---|---|
| Iupac Chemical Name | 5-(2,4-difluorophenoxy)-N-(2-(dimethylamino)ethyl)-1-isobutyl-1H -indazole-6-carboxamide |
| Synonyms | ARRY-797;ARRY 797;ARRY-371797;ARRY371797; |
| Molecular Formula | C22H26F2N4O2 |
| Molecular Weight | 416.46 |
| Smile | O=C(C1=CC2=C(C=C1OC3=CC=C(F)C=C3F)C=NN2CC(C)C)NCCN(C)C |
| InChiKey | IFGWYHGYNVGVRB-UHFFFAOYSA-N |
| InChi | InChI=1S/C22H26F2N4O2/c1-14(2)13-28-19-11-17(22(29)25-7-8-27(3)4)21(9-15(19)12-26-28)30-20-6-5-16(23)10-18(20)24/h5-6,9-12,14H,7-8,13H2,1-4H3,(H,25,29) |
| CAS Number | 1036404-17-7 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | off-white solid |
|---|---|
| Purity | 99% Min. |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO, not in water |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
